Literature DB >> 29789968

Exploring the mechanistic insights of Cas scaffolding protein family member 4 with protein tyrosine kinase 2 in Alzheimer's disease by evaluating protein interactions through molecular docking and dynamic simulations.

Mubashir Hassan1,2, Saba Shahzadi2,3, Hany Alashwal4, Nazar Zaki4, Sung-Yum Seo5, Ahmed A Moustafa6,7.   

Abstract

Cas scaffolding protein family member 4 and protein tyrosine kinase 2 are signaling proteins, which are involved in neuritic plaques burden, neurofibrillary tangles, and disruption of synaptic connections in Alzheimer's disease. In the current study, a computational approach was employed to explore the active binding sites of Cas scaffolding protein family member 4 and protein tyrosine kinase 2 proteins and their significant role in the activation of downstream signaling pathways. Sequential and structural analyses were performed on Cas scaffolding protein family member 4 and protein tyrosine kinase 2 to identify their core active binding sites. Molecular docking servers were used to predict the common interacting residues in both Cas scaffolding protein family member 4 and protein tyrosine kinase 2 and their involvement in Alzheimer's disease-mediated pathways. Furthermore, the results from molecular dynamic simulation experiment show the stability of targeted proteins. In addition, the generated root mean square deviations and fluctuations, solvent-accessible surface area, and gyration graphs also depict their backbone stability and compactness, respectively. A better understanding of CAS and their interconnected protein signaling cascade may help provide a treatment for Alzheimer's disease. Further, Cas scaffolding protein family member 4 could be used as a novel target for the treatment of Alzheimer's disease by inhibiting the protein tyrosine kinase 2 pathway.

Entities:  

Keywords:  Alzheimer’s disease; CASS4; Dynamic simulation; Molecular docking; PTK2

Mesh:

Substances:

Year:  2018        PMID: 29789968     DOI: 10.1007/s10072-018-3430-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  74 in total

1.  CAPRI: a Critical Assessment of PRedicted Interactions.

Authors:  Joël Janin; Kim Henrick; John Moult; Lynn Ten Eyck; Michael J E Sternberg; Sandor Vajda; Ilya Vakser; Shoshana J Wodak
Journal:  Proteins       Date:  2003-07-01

2.  VADAR: a web server for quantitative evaluation of protein structure quality.

Authors:  Leigh Willard; Anuj Ranjan; Haiyan Zhang; Hassan Monzavi; Robert F Boyko; Brian D Sykes; David S Wishart
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 3.  RAFTK/Pyk2-mediated cellular signalling.

Authors:  H Avraham; S Y Park; K Schinkmann; S Avraham
Journal:  Cell Signal       Date:  2000-03       Impact factor: 4.315

4.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

5.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

6.  The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences.

Authors:  B Bjellqvist; G J Hughes; C Pasquali; N Paquet; F Ravier; J C Sanchez; S Frutiger; D Hochstrasser
Journal:  Electrophoresis       Date:  1993-10       Impact factor: 3.535

Review 7.  Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members.

Authors:  Alexander Deneka; Vladislav Korobeynikov; Erica A Golemis
Journal:  Gene       Date:  2015-06-26       Impact factor: 3.688

8.  Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists.

Authors:  X Bi; C M Gall; J Zhou; G Lynch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 9.  Focal adhesion kinase and p53 signal transduction pathways in cancer.

Authors:  Vita M Golubovskaya; William Cance
Journal:  Front Biosci (Landmark Ed)       Date:  2010-06-01

Review 10.  Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Authors:  Celeste M Karch; Alison M Goate
Journal:  Biol Psychiatry       Date:  2014-05-17       Impact factor: 13.382

View more
  4 in total

1.  Understand the Functions of Scaffold Proteins in Cell Signaling by a Mesoscopic Simulation Method.

Authors:  Zhaoqian Su; Kalyani Dhusia; Yinghao Wu
Journal:  Biophys J       Date:  2020-10-14       Impact factor: 4.033

2.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

Review 3.  The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.

Authors:  Seda Sirin; Serap Nigdelioglu Dolanbay; Belma Aslim
Journal:  J Neural Transm (Vienna)       Date:  2022-04-16       Impact factor: 3.850

4.  Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic analysis.

Authors:  Mubashir Hassan; Sara Zahid; Hany Alashwal; Andrzej Kloczkowski; Ahmed A Moustafa
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.